Click for best price
Viral Vector Vaccines Market Size, Share 2023
Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Vaccines. This report contains market size and forecasts of Viral Vector Vaccines in global, including the following market information:
Global Viral Vector Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Viral Vector Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Viral Vector Vaccines companies in 2022 (%)
The global Viral Vector Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adenovirus Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Vector Vaccines include Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vector Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Type, 2022 (%)
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
Global Viral Vector Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Viral Vector Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Viral Vector Vaccines revenues share in global market, 2022 (%)
Key companies Viral Vector Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Viral Vector Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Bioscience Laboratories
Boehringer Ingelheim
Brammer Bio
Creative Biogene
GE Healthcare
Pfizer
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vector Vaccines, market overview.
Chapter 2: Global Viral Vector Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Viral Vector Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vector Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Viral Vector Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Viral Vector Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral Vector Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vector Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vector Vaccines Overall Market Size
2.1 Global Viral Vector Vaccines Market Size: 2022 VS 2029
2.2 Global Viral Vector Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Viral Vector Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Viral Vector Vaccines Players in Global Market
3.2 Top Global Viral Vector Vaccines Companies Ranked by Revenue
3.3 Global Viral Vector Vaccines Revenue by Companies
3.4 Global Viral Vector Vaccines Sales by Companies
3.5 Global Viral Vector Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Viral Vector Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Viral Vector Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viral Vector Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Viral Vector Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Viral Vector Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vector Vaccines Market Size Markets, 2022 & 2029
4.1.2 Adenovirus
4.1.3 Fowlpox Virus
4.1.4 Attenuated Yellow Fever
4.1.5 Vaccinia Virus Vectors
4.1.6 Others
4.2 By Type - Global Viral Vector Vaccines Revenue & Forecasts
4.2.1 By Type - Global Viral Vector Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Viral Vector Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Viral Vector Vaccines Sales & Forecasts
4.3.1 By Type - Global Viral Vector Vaccines Sales, 2018-2023
4.3.2 By Type - Global Viral Vector Vaccines Sales, 2024-2029
4.3.3 By Type - Global Viral Vector Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Viral Vector Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vector Vaccines Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Viral Vector Vaccines Revenue & Forecasts
5.2.1 By Application - Global Viral Vector Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Viral Vector Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Viral Vector Vaccines Sales & Forecasts
5.3.1 By Application - Global Viral Vector Vaccines Sales, 2018-2023
5.3.2 By Application - Global Viral Vector Vaccines Sales, 2024-2029
5.3.3 By Application - Global Viral Vector Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Viral Vector Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Viral Vector Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Viral Vector Vaccines Revenue & Forecasts
6.2.1 By Region - Global Viral Vector Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Viral Vector Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Viral Vector Vaccines Sales & Forecasts
6.3.1 By Region - Global Viral Vector Vaccines Sales, 2018-2023
6.3.2 By Region - Global Viral Vector Vaccines Sales, 2024-2029
6.3.3 By Region - Global Viral Vector Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Viral Vector Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Viral Vector Vaccines Sales, 2018-2029
6.4.3 US Viral Vector Vaccines Market Size, 2018-2029
6.4.4 Canada Viral Vector Vaccines Market Size, 2018-2029
6.4.5 Mexico Viral Vector Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Viral Vector Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Viral Vector Vaccines Sales, 2018-2029
6.5.3 Germany Viral Vector Vaccines Market Size, 2018-2029
6.5.4 France Viral Vector Vaccines Market Size, 2018-2029
6.5.5 U.K. Viral Vector Vaccines Market Size, 2018-2029
6.5.6 Italy Viral Vector Vaccines Market Size, 2018-2029
6.5.7 Russia Viral Vector Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Viral Vector Vaccines Market Size, 2018-2029
6.5.9 Benelux Viral Vector Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Viral Vector Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Viral Vector Vaccines Sales, 2018-2029
6.6.3 China Viral Vector Vaccines Market Size, 2018-2029
6.6.4 Japan Viral Vector Vaccines Market Size, 2018-2029
6.6.5 South Korea Viral Vector Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Viral Vector Vaccines Market Size, 2018-2029
6.6.7 India Viral Vector Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Viral Vector Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Viral Vector Vaccines Sales, 2018-2029
6.7.3 Brazil Viral Vector Vaccines Market Size, 2018-2029
6.7.4 Argentina Viral Vector Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Viral Vector Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Viral Vector Vaccines Sales, 2018-2029
6.8.3 Turkey Viral Vector Vaccines Market Size, 2018-2029
6.8.4 Israel Viral Vector Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Viral Vector Vaccines Market Size, 2018-2029
6.8.6 UAE Viral Vector Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Advanced Bioscience Laboratories
7.1.1 Advanced Bioscience Laboratories Company Summary
7.1.2 Advanced Bioscience Laboratories Business Overview
7.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Major Product Offerings
7.1.4 Advanced Bioscience Laboratories Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Advanced Bioscience Laboratories Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Viral Vector Vaccines Major Product Offerings
7.2.4 Boehringer Ingelheim Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Brammer Bio
7.3.1 Brammer Bio Company Summary
7.3.2 Brammer Bio Business Overview
7.3.3 Brammer Bio Viral Vector Vaccines Major Product Offerings
7.3.4 Brammer Bio Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Brammer Bio Key News & Latest Developments
7.4 Creative Biogene
7.4.1 Creative Biogene Company Summary
7.4.2 Creative Biogene Business Overview
7.4.3 Creative Biogene Viral Vector Vaccines Major Product Offerings
7.4.4 Creative Biogene Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Creative Biogene Key News & Latest Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Company Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Viral Vector Vaccines Major Product Offerings
7.5.4 GE Healthcare Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 GE Healthcare Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Viral Vector Vaccines Major Product Offerings
7.6.4 Pfizer Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Viral Vector Vaccines Major Product Offerings
7.7.4 Sanofi Viral Vector Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
8 Global Viral Vector Vaccines Production Capacity, Analysis
8.1 Global Viral Vector Vaccines Production Capacity, 2018-2029
8.2 Viral Vector Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Viral Vector Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Viral Vector Vaccines Supply Chain Analysis
10.1 Viral Vector Vaccines Industry Value Chain
10.2 Viral Vector Vaccines Upstream Market
10.3 Viral Vector Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Viral Vector Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Viral Vector Vaccines in Global Market
Table 2. Top Viral Vector Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Viral Vector Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Viral Vector Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Viral Vector Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Viral Vector Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Viral Vector Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Viral Vector Vaccines Product Type
Table 9. List of Global Tier 1 Viral Vector Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vector Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Viral Vector Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Viral Vector Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Viral Vector Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Viral Vector Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Viral Vector Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Viral Vector Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Viral Vector Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Viral Vector Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Viral Vector Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Viral Vector Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Viral Vector Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Viral Vector Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Viral Vector Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Viral Vector Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Viral Vector Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Viral Vector Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Viral Vector Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Viral Vector Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Viral Vector Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Viral Vector Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Viral Vector Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Viral Vector Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Viral Vector Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Viral Vector Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Viral Vector Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Viral Vector Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Viral Vector Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Viral Vector Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Viral Vector Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Viral Vector Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Viral Vector Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Viral Vector Vaccines Sales, (K Units), 2024-2029
Table 46. Advanced Bioscience Laboratories Company Summary
Table 47. Advanced Bioscience Laboratories Viral Vector Vaccines Product Offerings
Table 48. Advanced Bioscience Laboratories Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Advanced Bioscience Laboratories Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Viral Vector Vaccines Product Offerings
Table 52. Boehringer Ingelheim Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Brammer Bio Company Summary
Table 55. Brammer Bio Viral Vector Vaccines Product Offerings
Table 56. Brammer Bio Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Brammer Bio Key News & Latest Developments
Table 58. Creative Biogene Company Summary
Table 59. Creative Biogene Viral Vector Vaccines Product Offerings
Table 60. Creative Biogene Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Creative Biogene Key News & Latest Developments
Table 62. GE Healthcare Company Summary
Table 63. GE Healthcare Viral Vector Vaccines Product Offerings
Table 64. GE Healthcare Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. GE Healthcare Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Viral Vector Vaccines Product Offerings
Table 68. Pfizer Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Viral Vector Vaccines Product Offerings
Table 72. Sanofi Viral Vector Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Viral Vector Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Viral Vector Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Viral Vector Vaccines Production by Region, 2018-2023 (K Units)
Table 77. Global Viral Vector Vaccines Production by Region, 2024-2029 (K Units)
Table 78. Viral Vector Vaccines Market Opportunities & Trends in Global Market
Table 79. Viral Vector Vaccines Market Drivers in Global Market
Table 80. Viral Vector Vaccines Market Restraints in Global Market
Table 81. Viral Vector Vaccines Raw Materials
Table 82. Viral Vector Vaccines Raw Materials Suppliers in Global Market
Table 83. Typical Viral Vector Vaccines Downstream
Table 84. Viral Vector Vaccines Downstream Clients in Global Market
Table 85. Viral Vector Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Viral Vector Vaccines Segment by Type in 2022
Figure 2. Viral Vector Vaccines Segment by Application in 2022
Figure 3. Global Viral Vector Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral Vector Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Viral Vector Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Viral Vector Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Viral Vector Vaccines Revenue in 2022
Figure 9. By Type - Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Viral Vector Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Viral Vector Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Viral Vector Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Viral Vector Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 23. US Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 37. China Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Viral Vector Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Viral Vector Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Viral Vector Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Viral Vector Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Viral Vector Vaccines by Region, 2022 VS 2029
Figure 54. Viral Vector Vaccines Industry Value Chain
Figure 55. Marketing Channels
